Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells
- PMID: 3023050
- PMCID: PMC1167158
- DOI: 10.1002/j.1460-2075.1986.tb04540.x
Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells
Abstract
Certain newly established Epstein-Barr virus-containing Burkitt's lymphoma cell lines do not express the cytotoxic T-lymphocyte-detected membrane antigen (LYDMA) through which EBV infection is normally controlled by the host. When the EB virus recovered from these BL lines was used to transform peripheral blood lymphocytes from seronegative donors, the lymphoblastoid cell lines (LCLs) that arose were all LYDMA positive. This indicates that the LYDMA-negative nature of the BLs is not the result of a mutation in the resident viral genome but is rather a specific adaptation in those cells, perhaps permitting evasion of the host immune surveillance in tumour development. A comparison of the EBV gene expression in six LYDMA-negative and two LYDMA-positive BL lines and in their corresponding LCLs revealed that several of the BL lines did not express all of the viral gene products classically associated with latent transformation by EBV. Four out of eight cell lines showed restricted expression of the latent membrane protein (LMP) and/or the EB nuclear antigen, EBNA 2. A new level of EBV gene regulation therefore appears to be operating in some of the BL cell lines. The patterns of expression of EBV genes in the cell lines did not show any correlation with the known susceptibility of the lines to T cell killing.
Similar articles
-
Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.Blood. 1992 Jul 15;80(2):459-69. Blood. 1992. PMID: 1378321
-
Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.J Gen Virol. 1990 Jul;71 ( Pt 7):1481-95. doi: 10.1099/0022-1317-71-7-1481. J Gen Virol. 1990. PMID: 2165133
-
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.Int Immunol. 1992 Nov;4(11):1283-92. doi: 10.1093/intimm/4.11.1283. Int Immunol. 1992. PMID: 1282031
-
T cell recognition of Epstein-Barr virus associated lymphomas.Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review.
-
LYDMA-antigens and immunity against EBV-infected cells Epstein-Barr virus as a model for the study of host-infection interaction.Int J Biol Markers. 1987 May-Aug;2(2):125-32. doi: 10.1177/172460088700200212. Int J Biol Markers. 1987. PMID: 2837523 Review.
Cited by
-
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.EMBO J. 1987 Sep;6(9):2743-51. doi: 10.1002/j.1460-2075.1987.tb02568.x. EMBO J. 1987. PMID: 2824192 Free PMC article.
-
Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.J Virol. 1992 Feb;66(2):706-14. doi: 10.1128/JVI.66.2.706-714.1992. J Virol. 1992. PMID: 1370554 Free PMC article.
-
T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.J Exp Med. 1994 Apr 1;179(4):1297-305. doi: 10.1084/jem.179.4.1297. J Exp Med. 1994. PMID: 7511684 Free PMC article.
-
Epstein-Barr virus latent messages with shuffled leader exons: remnants of circumgenomic transcription?J Virol. 1995 Feb;69(2):1050-8. doi: 10.1128/JVI.69.2.1050-1058.1995. J Virol. 1995. PMID: 7815483 Free PMC article.
-
IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells.PLoS One. 2017 Oct 31;12(10):e0186614. doi: 10.1371/journal.pone.0186614. eCollection 2017. PLoS One. 2017. PMID: 29088270 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources